.jpg)
As one of the world’s leading cancer research and treatment centres, The Princess Margaret has been transforming standards of care for over 70 years. Every day, our renowned researchers are lighting the way forward through discoveries that are saving lives. The Invest in Research program fuels these incredible breakthroughs and creates brighter tomorrows for cancer patients everywhere.
As a member, you’ll be given exclusive access to research labs, updates from the researchers you’re supporting, and a chance to vote on the next projects we fund. Your support will help us Carry The Fire and create a world free from the fear of cancer. This is your chance to witness our next big breakthrough.
Investing in research is like having a front row seat to the future of cancer care — and the future looks bright. Your gift today will help fuel more breakthroughs that give brighter tomorrows to cancer patients everywhere.
To become a member of this groundbreaking group of thought leaders, email Alison Walters at investinresearch@thepmcf.ca, or give us a call at (437) 331-2408.
.jpg?lang=en-CA&ext=.jpg)
.jpg?lang=en-CA&ext=.jpg)
.jpg?lang=en-CA&ext=.jpg)
Our 2025 Grant Recipients
Hear from our grant recipients about how they're igniting breakthroughs in cancer research.
Dr. Aaron Schimmer
Research Director,
Princess Margaret Cancer Centre
When we invest in research, we automatically invest in our own care, in our people, and in our patients.
Past Recipients
-
2024
Dr. Steven Chan - Investigating CD59 as a Novel Therapeutic Target Against TP53-Mutated Acute Myeloid Leukemia
Dr. Housheng Hansen He - Tumour-Selective Induction of Immunogenic Cell Death via Organ-Tropic Delivery of Switchable mRNA for Non-Small Cell Lung Cancer Immunotherapy
Dr. Thomas Purdie - Machine Learning Generated Imaging to Close the Gap Between Diagnosis and Radiation Treatment Delivery
Read More -
2023
Dr. Cheryl Arrowsmith - A Novel Targeted Protein Degradation (TPD) Strategy to Evaluate the Role and Therapeutic Potential of NSD2 in Leukemia
Dr. Naoto Hirano - Development of Bi-specific T Cell Engagers (BiTEs) for the Treatment of Acute Myeloid Leukemia (AML)
Dr. Mohammad Mazhab-Jafari - Targeting De Novo Synthesis of Fatty Acids in Cancer Cells
Read More -
2022
Dr. Eric Lechman - Investigating Ciliopathy as a Predisposition for Pediatric Leukemia
Dr. Natasha Leighl - Accelerating Lung Cancer Diagnosis Through Liquid Biopsy
Dr. Shane Harding - Dynamic Heterogeneity of the Prostate Microenvironment in Patients Undergoing External Beam Radiotherapy -
2021
Dr. Geoffrey Liu - Lung Cancer Earlier Detection to Intercept Cancerous Relapsing Tumours (Lung EDICT)
Dr. Catherine O’Brien - Targeting Colorectal Cancer Cells in the Drug-tolerant Persister State
Dr. Anna Spreafico - Detecting and Monitoring Molecular Residual Disease (MRD) in High-Risk Melanoma Patients through Novel Circulating Tumour DNA (ctDNA) Profiling Technologies
-
2020
Dr. Phedias Diamandis - Growing Artificial Human Brains to Refine Glioblastoma Drug Development Efforts
Dr. Marianne Koritzinsky - Mechanisms of PRDX4 Addiction in Pancreatic Cancer
Contact Us
For more information on the Invest in Research program, email Alison Walters at investinresearch@thepmcf.ca or give us a call at (437) 331-2408.